(V541) |
1-Year Outcomes with Abciximab and Unfractionated Heparin versus Bivalirudin During Percutaneous Coronary Interventions in Patients with NSTEMI: Updated Results from the ISAR-REACT 4 trial |
|
S. Schulz, A. Kastrati, M. Ferenc, S. Massberg, A. Birkmeier, K.-L. Laugwitz, S. Kufner, M. Gick, M. Dommasch, H. Schühlen, A. Schömig, P. Berger, J. Mehilli, F.-J. Neumann (München, Bad Krozingen, Berlin; Danville, US) |
(V542) |
Impact of early reperfusion therapy in patients with NSTEMI - results of the OPTAMI registry |
|
J. C. Karcher, K. Kouraki, T. Limbourg, U. Zeymer, R. Zahn, A. K. Gitt (Ludwigshafen) |
(V543) |
Impact of atrial fibrillation on hospital and one year outcome of myocardial infarction - results of the OPTAMI registry |
|
K. Kouraki, J. C. Karcher, T. Limbourg, U. Zeymer, R. Zahn, A. K. Gitt (Ludwigshafen) |
(V544) |
Plasma Osmolality Predicts Clinical Outcome in Patients Admitted With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention and Stent Implantation |
|
M. Rohla, M. Freynhofer, I. Tentzeris, R. Jarai, S. Farhan, J. Wojta, K. Huber, T. W. Weiss (Wien, AT) |
(V545) |
High rate of guideline adherent therapy in patients with acute coronary syndromes in Germany. Results of the EPICOR-Registry. |
|
U. Zeymer, H. Heuer, P. L. Schwimmbeck, S. Genth-Zotz, C. Nienaber, V. Weck (Ludwigshafen, Dortmund, Leverkusen, Mainz, Rostock, Wedel) |
(V546) |
Renal Failure But Not Diabetes Determines Hospital Mortaliy In Patients With NSTE-ACS- Results Of The Euro Heart Survey ACS Registry |
|
A. K. Gitt, M. Hochadel, R. Zahn, U. Zeymer, W. Wojakowski, M. Tendera, F. Schiele, J.-P. Bassand on behalf of Euro Heart (Ludwigshafen; Katowice, PL; Besancon, FR) |